CY1107630T1 - Συστηματα απορριψης των διαδερμatικων συσκευων αποθεσης ωστε να αποτραπει η καταχρηση των δραστικων ουσιων που περιεχονται σε αυτες - Google Patents

Συστηματα απορριψης των διαδερμatικων συσκευων αποθεσης ωστε να αποτραπει η καταχρηση των δραστικων ουσιων που περιεχονται σε αυτες

Info

Publication number
CY1107630T1
CY1107630T1 CY20071100668T CY071100668T CY1107630T1 CY 1107630 T1 CY1107630 T1 CY 1107630T1 CY 20071100668 T CY20071100668 T CY 20071100668T CY 071100668 T CY071100668 T CY 071100668T CY 1107630 T1 CY1107630 T1 CY 1107630T1
Authority
CY
Cyprus
Prior art keywords
transdermal
active ingredient
delivery device
transdermal delivery
interatrative
Prior art date
Application number
CY20071100668T
Other languages
Greek (el)
English (en)
Inventor
Carl J Baker
Ihor Shevchuk
Original Assignee
Euro-Celtique S.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Euro-Celtique S.A. filed Critical Euro-Celtique S.A.
Publication of CY1107630T1 publication Critical patent/CY1107630T1/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/485—Morphinan derivatives, e.g. morphine, codeine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/36—Opioid-abuse
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B09—DISPOSAL OF SOLID WASTE; RECLAMATION OF CONTAMINATED SOIL
    • B09B—DISPOSAL OF SOLID WASTE NOT OTHERWISE PROVIDED FOR
    • B09B3/00—Destroying solid waste or transforming solid waste into something useful or harmless
    • B09B3/70—Chemical treatment, e.g. pH adjustment or oxidation
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B09—DISPOSAL OF SOLID WASTE; RECLAMATION OF CONTAMINATED SOIL
    • B09B—DISPOSAL OF SOLID WASTE NOT OTHERWISE PROVIDED FOR
    • B09B2101/00—Type of solid waste
    • B09B2101/65—Medical waste
    • B09B2101/68—Transdermal patches

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Toxicology (AREA)
  • Environmental & Geological Engineering (AREA)
  • Emergency Medicine (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Addiction (AREA)
  • Dermatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Media Introduction/Drainage Providing Device (AREA)
  • Adhesives Or Adhesive Processes (AREA)
  • Processing Of Solid Wastes (AREA)
CY20071100668T 2002-06-10 2007-05-17 Συστηματα απορριψης των διαδερμatικων συσκευων αποθεσης ωστε να αποτραπει η καταχρηση των δραστικων ουσιων που περιεχονται σε αυτες CY1107630T1 (el)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US38780002P 2002-06-10 2002-06-10
EP03757468A EP1513532B1 (en) 2002-06-10 2003-06-10 Disposal systems of transdermal delivery devices to prevent misuse of the active agents contained therein

Publications (1)

Publication Number Publication Date
CY1107630T1 true CY1107630T1 (el) 2013-04-18

Family

ID=29736367

Family Applications (1)

Application Number Title Priority Date Filing Date
CY20071100668T CY1107630T1 (el) 2002-06-10 2007-05-17 Συστηματα απορριψης των διαδερμatικων συσκευων αποθεσης ωστε να αποτραπει η καταχρηση των δραστικων ουσιων που περιεχονται σε αυτες

Country Status (22)

Country Link
US (2) US20040033255A1 (enExample)
EP (4) EP1513532B1 (enExample)
JP (3) JP4949625B2 (enExample)
KR (2) KR101407131B1 (enExample)
CN (2) CN101455649B (enExample)
AT (1) ATE355061T1 (enExample)
AU (2) AU2003251482A1 (enExample)
CA (1) CA2488915C (enExample)
CY (1) CY1107630T1 (enExample)
DE (1) DE60312160T2 (enExample)
DK (1) DK1513532T3 (enExample)
EA (1) EA007240B1 (enExample)
ES (1) ES2283812T3 (enExample)
IL (1) IL165517A0 (enExample)
MX (1) MXPA04012333A (enExample)
NO (1) NO334455B1 (enExample)
NZ (1) NZ537180A (enExample)
PT (1) PT1513532E (enExample)
SI (1) SI1513532T1 (enExample)
UA (1) UA82194C2 (enExample)
WO (1) WO2003103673A1 (enExample)
ZA (1) ZA200409495B (enExample)

Families Citing this family (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040202717A1 (en) * 2003-04-08 2004-10-14 Mehta Atul M. Abuse-resistant oral dosage forms and method of use thereof
US8790689B2 (en) * 2003-04-30 2014-07-29 Purdue Pharma L.P. Tamper resistant transdermal dosage form
BRPI0409945A (pt) * 2003-04-30 2006-04-25 Purdue Pharma Lp forma de dosagem resistente à alteração
US20070191815A1 (en) 2004-09-13 2007-08-16 Chrono Therapeutics, Inc. Biosynchronous transdermal drug delivery
US7867511B2 (en) 2004-01-23 2011-01-11 Travanti Pharma Inc. Abuse potential reduction in abusable substance dosage form
US8535711B2 (en) * 2004-01-23 2013-09-17 Teikoku Pharma Usa, Inc. Medication disposal system
EP1718258B1 (en) * 2004-02-23 2009-03-25 Euro-Celtique S.A. Abuse resistance opioid transdermal delivery device
US20060045897A1 (en) * 2004-08-27 2006-03-02 Aso Corporation Occlusive articles for wart treatment
US8252321B2 (en) 2004-09-13 2012-08-28 Chrono Therapeutics, Inc. Biosynchronous transdermal drug delivery for longevity, anti-aging, fatigue management, obesity, weight loss, weight management, delivery of nutraceuticals, and the treatment of hyperglycemia, alzheimer's disease, sleep disorders, parkinson's disease, aids, epilepsy, attention deficit disorder, nicotine addiction, cancer, headache and pain control, asthma, angina, hypertension, depression, cold, flu and the like
WO2006069008A1 (en) * 2004-12-22 2006-06-29 Vesta Medical, Llc Compositions and devices for inactivation of pharmaceuticals to facilitate waste disposal, and methods thereof
US20070014839A1 (en) * 2005-07-18 2007-01-18 Stefan Bracht Decomposer film for transdermal patches
US9522188B2 (en) * 2005-12-13 2016-12-20 Biodelivery Sciences International, Inc. Abuse resistant transmucosal drug delivery device
ES2577390T3 (es) 2006-07-21 2016-07-14 Biodelivery Sciences International, Inc. Dispositivos de administración transmucosa con mayor captación
WO2008115811A2 (en) * 2007-03-16 2008-09-25 Endo Pharmaceuticals, Inc. Transdermal delivery form disposal systems and methods
US9700552B2 (en) 2008-02-28 2017-07-11 Syntropharma Limited Pharmaceutical compositions for treatment of addiction
CA2718943A1 (en) * 2008-03-26 2009-10-01 Alltranz Inc. Abuse deterrent transdermal formulations of opiate agonists and agonist-antagonists
DE202008004785U1 (de) * 2008-04-04 2009-08-13 Grünenthal GmbH Entsorgungsvorrichtung
US8329210B2 (en) * 2008-09-23 2012-12-11 Pharmapatch, Llc Twin transdermal drug delivery patch
TWI630208B (zh) 2008-12-08 2018-07-21 歐陸斯迪公司 二氫羥戊甲嗎啡
US8507182B2 (en) * 2009-06-09 2013-08-13 Eastman Kodak Company Method of providing lithographic printing plates
DE102009036485B4 (de) * 2009-08-07 2012-10-04 Lts Lohmann Therapie-Systeme Ag Mittel zur zerstörenden Entsorgung von medizinischen Wirkstoffen in transdermalen therapeutischen Systemen
US8952038B2 (en) 2010-03-26 2015-02-10 Philip Morris Usa Inc. Inhibition of undesired sensory effects by the compound camphor
MX350636B (es) 2010-03-26 2017-09-12 Philip Morris Products Sa Inhibicion de irritacion sensorial durante el consumo de productos de tabaco no fumables.
US20130017259A1 (en) 2011-07-06 2013-01-17 The Parkinson's Institute Compositions and Methods for Treatment of Symptoms in Parkinson's Disease Patients
MX352959B (es) 2011-08-18 2017-12-15 Biodelivery Sciences Int Inc Dispositivos mucoadhesivos resistentes al abuso para el suministro de buprenorfina.
CN103764129A (zh) 2011-09-30 2014-04-30 帝国制药美国公司 透皮贴剂处置系统
CN103764092A (zh) 2011-09-30 2014-04-30 帝国制药美国公司 普通药物处置系统
US9901539B2 (en) 2011-12-21 2018-02-27 Biodelivery Sciences International, Inc. Transmucosal drug delivery devices for use in chronic pain relief
US10105487B2 (en) 2013-01-24 2018-10-23 Chrono Therapeutics Inc. Optimized bio-synchronous bioactive agent delivery system
GB201309654D0 (en) 2013-05-30 2013-07-17 Euro Celtique Sa Method
JP2018511355A (ja) 2015-01-28 2018-04-26 クロノ セラピューティクス インコーポレイテッドＣｈｒｏｎｏ Ｔｈｅｒａｐｅｕｔｉｃｓ Ｉｎｃ． 薬剤送達方法及びシステム
US10575983B2 (en) 2015-02-19 2020-03-03 Candesant Biomedical, Inc. Medical devices for generating heat and methods of treatment using same
AU2016228779A1 (en) 2015-03-12 2017-09-07 Chrono Therapeutics Inc. Craving input and support system
GB201520390D0 (en) * 2015-11-19 2016-01-06 Euro Celtique Sa Composition
ES2957234T3 (es) 2016-03-24 2024-01-15 Medrx Co Ltd Preparación de parche con características de prevención del uso incorrecto de sustancias
US10532385B2 (en) * 2016-06-29 2020-01-14 Disposerx, Inc. Disposal of medicaments
WO2018129304A1 (en) 2017-01-06 2018-07-12 Chrono Therapeutics Inc. Transdermal drug delivery devices and methods
JPWO2019059377A1 (ja) 2017-09-22 2020-11-12 株式会社 メドレックス 再貼付不可能な貼付剤
US11389844B2 (en) 2018-03-20 2022-07-19 Verde Environmental Technologies, Inc. Blister pack disposal system
AU2019279884B2 (en) 2018-05-29 2025-01-30 Morningside Venture Investments Limited Drug delivery methods and systems
JP2022507660A (ja) 2018-11-16 2022-01-18 モーニングサイド ベンチャー インベストメンツ リミテッド 温度によって調節される経皮薬剤送達システム
MX2022006613A (es) * 2019-12-10 2022-07-11 Candesant Biomedical Inc Metodos y sistemas para desechar parches de metal alcalino.
EP4378432A3 (en) 2019-12-10 2024-07-31 Candesant Biomedical, Inc. Medical device for generating heat
CN119588727B (zh) * 2024-12-06 2025-09-26 奕瑞新材料科技（太仓）有限公司 一种碘化铯闪烁屏用激活剂提纯系统、提纯方法及应用

Family Cites Families (81)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3527864A (en) 1966-11-18 1970-09-08 Procter & Gamble Compositions for topical application to animal tissue and method of enhancing penetration thereof
US3540580A (en) * 1967-07-03 1970-11-17 Borden Inc Heat-seal adhesive and package
US3472931A (en) 1969-01-17 1969-10-14 Foster Milburn Co Percutaneous absorption with lower alkyl amides
US3903256A (en) 1972-02-07 1975-09-02 Procter & Gamble Compositions for topical application of animal tissue and method of enhancing penetration thereof
US3896238A (en) 1972-04-05 1975-07-22 Procter & Gamble Dermatological compositions
US3952099A (en) 1973-03-13 1976-04-20 The Procter & Gamble Company Dermatological compositions
US4046886A (en) 1975-01-17 1977-09-06 The Procter & Gamble Company Dermatological compositions
US3989816A (en) 1975-06-19 1976-11-02 Nelson Research & Development Company Vehicle composition containing 1-substituted azacycloheptan-2-ones
US4316893A (en) 1975-06-19 1982-02-23 Nelson Research & Development Co. Vehicle composition containing 1-substituted azacycloalkan-2-ones
US4405616A (en) 1975-06-19 1983-09-20 Nelson Research & Development Company Penetration enhancers for transdermal drug delivery of systemic agents
US4130643A (en) 1976-01-12 1978-12-19 The Procter & Gamble Company Dermatological compositions
US4060084A (en) 1976-09-07 1977-11-29 Alza Corporation Method and therapeutic system for providing chemotherapy transdermally
US4335115A (en) 1976-11-01 1982-06-15 The Procter & Gamble Company Anti-acne composition
US4166058A (en) * 1978-08-11 1979-08-28 The Goodyear Tire & Rubber Company Heat sensitive primer exhibiting color change and containing a resin blend, elemental sulfur, and a dye
US4326566A (en) 1979-09-11 1982-04-27 N. V. Weefautomaten Picanol Color selector
US4299826A (en) 1979-10-12 1981-11-10 The Procter & Gamble Company Anti-acne composition
US4248748A (en) * 1980-02-04 1981-02-03 Minnesota Mining And Manufacturing Company Heat-activated adhesive
DE3047635A1 (de) * 1980-12-17 1982-07-22 Hilti AG, 9494 Schaan Klebeverfahren mittels schmelzklebstoff sowie mittel zur durchfuehrung des verfahrens
US4379454A (en) 1981-02-17 1983-04-12 Alza Corporation Dosage for coadministering drug and percutaneous absorption enhancer
US4343798A (en) 1981-06-23 1982-08-10 The Procter & Gamble Company Topical antimicrobial anti-inflammatory compositions
US4560553A (en) 1981-07-07 1985-12-24 Merck & Co., Inc. Use of eucalyptol for enhancing skin permeation of bio-affecting agents
US4510621A (en) * 1983-06-30 1985-04-09 Arvey Corporation Self-sealing pouch for forming adhesive-to-adhesive seal
US4588580B2 (en) 1984-07-23 1999-02-16 Alaz Corp Transdermal administration of fentanyl and device therefor
JPS61103840A (ja) 1984-10-26 1986-05-22 Nitto Electric Ind Co Ltd 外皮投与用組成物
US4806341A (en) 1985-02-25 1989-02-21 Rutgers, The State University Of New Jersey Transdermal absorption dosage unit for narcotic analgesics and antagonists and process for administration
US5066648A (en) 1985-11-29 1991-11-19 Merck & Co., Inc. Pyroglutamic acid esters used as dermal penetration enhancers for drugs
US4973968A (en) 1986-03-07 1990-11-27 Plessey Overseas Limited Radar system for determining first time around targets from multiple time around targets
US4863970A (en) 1986-11-14 1989-09-05 Theratech, Inc. Penetration enhancement with binary system of oleic acid, oleins, and oleyl alcohol with lower alcohols
US4940586A (en) 1987-02-26 1990-07-10 Alza Corporation Skin permeation enhancer compositions using sucrose esters
US4746515A (en) 1987-02-26 1988-05-24 Alza Corporation Skin permeation enhancer compositions using glycerol monolaurate
US4879275A (en) 1987-09-30 1989-11-07 Nelson Research & Development Co. Penetration enhancers for transdermal delivery of systemic agent
US5225473A (en) * 1987-11-25 1993-07-06 Minnesota Mining And Manufacturing Company Pressure-sensitive adhesives
GB8811669D0 (en) * 1988-05-17 1988-06-22 Alcan Int Ltd Colour-changeable adhesive
US5164406A (en) 1988-06-02 1992-11-17 Bristol-Myers Squibb Co. Method for enhancing transdermal penetration and compositions useful therein
US5378730A (en) 1988-06-09 1995-01-03 Alza Corporation Permeation enhancer comprising ethanol and monoglycerides
US5641504A (en) 1988-06-09 1997-06-24 Alza Corporation Skin permeation enhancer compositions using glycerol monolinoleate
US4960771A (en) 1988-07-12 1990-10-02 Rajadhyaksha Vithal J Oxazolidinone penetration enhancing compounds
US5236714A (en) 1988-11-01 1993-08-17 Alza Corporation Abusable substance dosage form having reduced abuse potential
US4956171A (en) * 1989-07-21 1990-09-11 Paco Pharmaceutical Services, Inc. Transdermal drug delivery using a dual permeation enhancer and method of performing the same
US5750134A (en) 1989-11-03 1998-05-12 Riker Laboratories, Inc. Bioadhesive composition and patch
US5240711A (en) 1989-11-29 1993-08-31 Lts Lohmann Therapie-Systeme Gmbh & Co. Kg Transdermal therapeutic system comprising as active component buprenorphine
US5069909A (en) 1990-06-20 1991-12-03 Cygnus Therapeutic Systems Transdermal administration of buprenorphine
JP3196851B2 (ja) * 1991-04-01 2001-08-06 積水化学工業株式会社 医療用貼付剤
US5227169A (en) 1991-05-17 1993-07-13 Theratech, Inc. Sorbitan esters as skin permeation enhancers
US5308887A (en) * 1991-05-23 1994-05-03 Minnesota Mining & Manufacturing Company Pressure-sensitive adhesives
US5149538A (en) * 1991-06-14 1992-09-22 Warner-Lambert Company Misuse-resistive transdermal opioid dosage form
US5981666A (en) * 1991-07-12 1999-11-09 Adhesives Research, Inc. Method for the production of a high performance pressure sensitive adhesive
US5232702A (en) * 1991-07-22 1993-08-03 Dow Corning Corporation Silicone pressure sensitive adhesive compositons for transdermal drug delivery devices and related medical devices
US5238933A (en) 1991-10-28 1993-08-24 Sri International Skin permeation enhancer compositions
US5229130A (en) 1991-12-20 1993-07-20 Cygnus Therapeutics Systems Vegetable oil-based skin permeation enhancer compositions, and associated methods and systems
CA2097163C (en) 1992-06-01 2002-07-30 Marianna Foldvari Topical patch for liposomal drug delivery system
US5308625A (en) 1992-09-02 1994-05-03 Cygnus Therapeutic Systems Enhancement of transdermal drug delivery using monoalkyl phosphates and other absorption promoters
US6162456A (en) 1992-09-24 2000-12-19 Ortho-Mcneil Pharmaceutical, Inc. Adhesive transdermal drug delivery matrix of a physical blend of hydrophilic and hydrophobic polymers
JPH0710742Y2 (ja) * 1993-02-05 1995-03-15 日本臓器製薬株式会社 救急絆創膏
DE59409873D1 (de) * 1993-04-20 2001-10-25 Hexal Ag Wirkstoffpflaster
US5520385A (en) * 1993-07-30 1996-05-28 Composite Development Corporation Article assembled with thermoreponsive material and method
NZ274711A (en) 1993-09-29 1996-11-26 Alza Corp Composition for administration of active agent by application to a body surface or membrane comprising permeability enhancing amount of monoglyceride(s) and lactate ester(s)
US5470529A (en) * 1994-03-08 1995-11-28 Sumitomo Metal Industries, Ltd. High tensile strength steel sheet having improved formability
US5420106A (en) 1994-03-22 1995-05-30 Bristol-Myers Squibb Company Method and composition having enhanced alpha-hydroxy acid skin permeation and retention
JP2819236B2 (ja) * 1994-05-06 1998-10-30 日東電工株式会社 経皮吸収製剤
US5540934A (en) 1994-06-22 1996-07-30 Touitou; Elka Compositions for applying active substances to or through the skin
GB9425783D0 (en) * 1994-12-21 1995-02-22 Ethical Pharma Ltd Packaging of patches
US5573778A (en) * 1995-03-17 1996-11-12 Adhesives Research, Inc. Drug flux enhancer-tolerant pressure sensitive adhesive composition
US5882676A (en) 1995-05-26 1999-03-16 Alza Corporation Skin permeation enhancer compositions using acyl lactylates
US5785991A (en) 1995-06-07 1998-07-28 Alza Corporation Skin permeation enhancer compositions comprising glycerol monolaurate and lauryl acetate
US5834468A (en) 1995-07-07 1998-11-10 Zeneca Limited Substituted aryl and heteroaryl compounds as E-type prostaglandin antagonists
WO1997004835A1 (de) * 1995-07-28 1997-02-13 Novartis Ag Transdermales system
US5902603A (en) 1995-09-14 1999-05-11 Cygnus, Inc. Polyurethane hydrogel drug reservoirs for use in transdermal drug delivery systems, and associated methods of manufacture and use
US5837289A (en) 1996-07-23 1998-11-17 Grasela; John C. Transdermal delivery of medications using a combination of penetration enhancers
ES2191834T3 (es) 1996-10-24 2003-09-16 Alza Corp Agentes que facilitan la permeacion y destinados para composiciones, dispositivos y procedimientos de aporte transdermico de medicamentos.
US5912009A (en) 1996-10-30 1999-06-15 Theratech, Inc. Fatty acid esters of glycolic acid and its salts
DE19649534B4 (de) * 1996-11-29 2004-05-06 Lts Lohmann Therapie-Systeme Ag Verpackung aus Verbundpackstoff zum Verpacken von wirkstoffhaltigen Pflastern
US5968547A (en) 1997-02-24 1999-10-19 Euro-Celtique, S.A. Method of providing sustained analgesia with buprenorphine
US5804215A (en) * 1997-03-21 1998-09-08 L. Perrigo Company Transdermal patch disposal system and method
US6017983A (en) * 1998-01-29 2000-01-25 Alpha Metals, Inc. Color indicator for completion of polymerization for thermosets
DE19901085C2 (de) * 1999-01-14 2003-12-18 Lohmann Therapie Syst Lts Transdermales therapeutisches System mit einer selbstklebenden Matrix, enthaltend organische Säure-Additionssalze von Alkaloiden des Morphin- bzw. Morphinantyps
US7018649B2 (en) * 2000-10-23 2006-03-28 Euro-Celtique, S.A. Felodipine transdermal device and methods
US6682757B1 (en) * 2000-11-16 2004-01-27 Euro-Celtique, S.A. Titratable dosage transdermal delivery system
DE60235555D1 (de) * 2001-04-23 2010-04-15 Euro Celtique Sa Entsorgungssystem für transdermale dosierformen
DK2316439T3 (en) * 2001-05-01 2015-08-10 Euro Celtique Sa Abuse-proof transdermal systems containing opioids
US6638981B2 (en) * 2001-08-17 2003-10-28 Epicept Corporation Topical compositions and methods for treating pain

Also Published As

Publication number Publication date
KR20110120358A (ko) 2011-11-03
DK1513532T3 (da) 2007-07-02
ES2283812T3 (es) 2007-11-01
KR20050020977A (ko) 2005-03-04
EP1837023A1 (en) 2007-09-26
CA2488915A1 (en) 2003-12-18
JP2011016802A (ja) 2011-01-27
MXPA04012333A (es) 2005-02-25
JP5898242B2 (ja) 2016-04-06
CN101455649B (zh) 2014-02-26
EP1513532B1 (en) 2007-02-28
EP2266565A1 (en) 2010-12-29
JP2005538058A (ja) 2005-12-15
EP2298302A1 (en) 2011-03-23
EP1513532A1 (en) 2005-03-16
DE60312160T2 (de) 2007-10-31
PT1513532E (pt) 2007-05-31
IL165517A0 (en) 2006-01-15
NZ537180A (en) 2008-03-28
AU2003251482A1 (en) 2003-12-22
NO334455B1 (no) 2014-03-10
US20040033255A1 (en) 2004-02-19
UA82194C2 (uk) 2008-03-25
CN1658878A (zh) 2005-08-24
KR101407131B1 (ko) 2014-06-19
JP4949625B2 (ja) 2012-06-13
EA200401564A1 (ru) 2005-08-25
AU2009217420A1 (en) 2009-10-15
JP2014088422A (ja) 2014-05-15
CA2488915C (en) 2011-10-04
SI1513532T1 (sl) 2007-08-31
WO2003103673A1 (en) 2003-12-18
NO20050126L (no) 2005-01-10
JP5507367B2 (ja) 2014-05-28
EA007240B1 (ru) 2006-08-25
CN101455649A (zh) 2009-06-17
AU2009217420B2 (en) 2013-06-13
ZA200409495B (en) 2006-05-31
CN100525767C (zh) 2009-08-12
DE60312160D1 (de) 2007-04-12
US20080274168A1 (en) 2008-11-06
ATE355061T1 (de) 2006-03-15

Similar Documents

Publication Publication Date Title
DK1513532T3 (da) Bortskaffelsessystemer til transdermale administrationsanordninger for at hindre misbrug af de aktive stoffer, der er indeholdt deri
DE60316579D1 (de) System zur abgabe von wirkstoffen mit einem hydrophoben cellulose-derivat
US9375510B2 (en) Transdermal adhesive compositions, devices and methods
DE60331552D1 (de) Darreichungssysteme von wirkstoffen mit poly(ethylene-co(meth)akrylate, medizinische vorrichtung und verfahren
NO982764L (no) Oppfinnelse og anordning for transdermal anordning for avgivelse av flurbiprofen
WO2009014897A3 (en) Antistatic article, method of making the same, and display device having the same
WO2004039427A3 (en) Transdermal delivery system for anti-emetic medication
ATE317711T1 (de) Elektropolymerisierbare monomere und polymerbeschichtungen auf implantierbaren geräten
DK1957130T3 (da) Hydrofilt overtræk omfattende en polyelektrolyt
BR112019005615A2 (pt) filmes respiráveis com propriedades de barreira microbiana
Bal et al. Preparation and characterization of p H responsive poly (methacrylic acid‐acrylamide‐N‐hydroxyethyl acrylamide) hydrogels for drug delivery systems
ATE460437T1 (de) Polymere von fluormonomeren und hydrophilen monomeren
ES2531326T3 (es) Sistemas de red polimérica para dispositivos médicos y métodos de uso
WO1999055286A3 (en) Drug-containing transdermal patches, plastisols and adhesives
CN101522146A (zh) 具有高活性成分利用率和定量给药精确度的透皮治疗系统
ATE448812T1 (de) Beschichtung von stents mit verzögerter wirkstofffreisetzung
ATE200028T1 (de) Transdermale abgabe vorrichtung
WO2008008334A3 (en) Drug-eluting implantable medical device with free radical scavenger for protecting drugs during sterilization and related method
US20140170206A1 (en) Composition for the transdermal delivery of fentanyl
HUP9801989A2 (hu) Ace-gátló anyagokat tartalmazó, transzdermálisan alkalmazható gyógyszerek
ATE367803T1 (de) Subcutane implantate mit begrenzter initialer wirkstoff-freisetzung und deren anschliessende lineare veränderliche verlängerte freisetzung
JP2002518430A5 (enExample)
CZ287678B6 (en) Transdermal therapeutic system (TTS) for testosterone administration
DE60315280D1 (de) Transdermale pflaster mit einer adhäsiven siliconmatrix stabilisiert mit methacryl copolymeren
JP3480984B2 (ja) 医療用貼付剤